Rival Drug Data Co. Hits IMS Health With Antitrust Lawsuit
Philadelphia-based Symphony Health Solutions alleges IMS has entered into exclusive long-term agreements with pharmacies and other health care providers, preventing would-be competitors from accessing “a substantial percentage” of U.S. drug and health care data.
The result, Symphony Health claims, has eliminated meaningful market...
To view the full article, register now.